HOLCIM LTD (HLBN.DE) Fundamental Analysis & Valuation

FRA:HLBN • CH0012214059

Current stock price

70.7 EUR
-1.84 (-2.54%)
Last:

This HLBN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. HLBN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year HLBN was profitable.
  • HLBN had a positive operating cash flow in the past year.
  • HLBN had positive earnings in each of the past 5 years.
  • HLBN had a positive operating cash flow in each of the past 5 years.
HLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFHLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

1.2 Ratios

  • HLBN has a Return On Assets of 39.22%. This is amongst the best in the industry. HLBN outperforms 100.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 85.70%, HLBN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • HLBN's Return On Invested Capital of 5.31% is in line compared to the rest of the industry. HLBN outperforms 43.75% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HLBN is in line with the industry average of 7.62%.
Industry RankSector Rank
ROA 39.22%
ROE 85.7%
ROIC 5.31%
ROA(3y)16.79%
ROA(5y)11.98%
ROE(3y)36.04%
ROE(5y)25.57%
ROIC(3y)5.85%
ROIC(5y)5.22%
HLBN.DE Yearly ROA, ROE, ROICHLBN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

  • HLBN's Profit Margin of 83.81% is amongst the best of the industry. HLBN outperforms 100.00% of its industry peers.
  • HLBN's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 14.18%, HLBN is doing good in the industry, outperforming 68.75% of the companies in the same industry.
  • HLBN's Operating Margin has improved in the last couple of years.
  • HLBN has a Gross Margin of 42.34%. This is in the lower half of the industry: HLBN underperforms 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of HLBN has remained more or less at the same level.
Industry RankSector Rank
OM 14.18%
PM (TTM) 83.81%
GM 42.34%
OM growth 3Y12.41%
OM growth 5Y2.33%
PM growth 3Y95.17%
PM growth 5Y63.13%
GM growth 3Y2.1%
GM growth 5Y0.23%
HLBN.DE Yearly Profit, Operating, Gross MarginsHLBN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

4

2. HLBN.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HLBN is creating some value.
  • The number of shares outstanding for HLBN has been increased compared to 1 year ago.
  • HLBN has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, HLBN has a worse debt to assets ratio.
HLBN.DE Yearly Shares OutstandingHLBN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
HLBN.DE Yearly Total Debt VS Total AssetsHLBN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.84 indicates that HLBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.84, HLBN is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • HLBN has a debt to FCF ratio of 5.35. This is a neutral value as HLBN would need 5.35 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.35, HLBN is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • HLBN has a Debt/Equity ratio of 0.51. This is a neutral value indicating HLBN is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.51, HLBN is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 5.35
Altman-Z 2.84
ROIC/WACC1.2
WACC4.43%
HLBN.DE Yearly LT Debt VS Equity VS FCFHLBN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • HLBN has a Current Ratio of 1.32. This is a normal value and indicates that HLBN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.32, HLBN is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.09 indicates that HLBN should not have too much problems paying its short term obligations.
  • HLBN has a Quick ratio (1.09) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.09
HLBN.DE Yearly Current Assets VS Current LiabilitesHLBN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

4

3. HLBN.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 355.07% over the past year.
  • Measured over the past years, HLBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 54.06% on average per year.
  • The Revenue for HLBN has decreased by -40.46% in the past year. This is quite bad
  • The Revenue has been decreasing by -7.44% on average over the past years.
EPS 1Y (TTM)355.07%
EPS 3Y63.31%
EPS 5Y54.06%
EPS Q2Q%-131.27%
Revenue 1Y (TTM)-40.46%
Revenue growth 3Y-18.63%
Revenue growth 5Y-7.44%
Sales Q2Q%-42.23%

3.2 Future

  • Based on estimates for the next years, HLBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.55% on average per year.
  • HLBN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.30% yearly.
EPS Next Y8.17%
EPS Next 2Y11.28%
EPS Next 3Y11.16%
EPS Next 5Y9.55%
Revenue Next Year2.7%
Revenue Next 2Y5.02%
Revenue Next 3Y5.02%
Revenue Next 5Y6.3%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HLBN.DE Yearly Revenue VS EstimatesHLBN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
HLBN.DE Yearly EPS VS EstimatesHLBN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

5

4. HLBN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 2.73, the valuation of HLBN can be described as very cheap.
  • Based on the Price/Earnings ratio, HLBN is valued cheaper than 100.00% of the companies in the same industry.
  • HLBN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.89.
  • A Price/Forward Earnings ratio of 17.60 indicates a rather expensive valuation of HLBN.
  • HLBN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HLBN is more expensive than 68.75% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, HLBN is valued a bit cheaper.
Industry RankSector Rank
PE 2.73
Fwd PE 17.6
HLBN.DE Price Earnings VS Forward Price EarningsHLBN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HLBN is valued more expensive than 87.50% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HLBN is valued more expensive than 81.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.3
EV/EBITDA 12.13
HLBN.DE Per share dataHLBN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • HLBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of HLBN may justify a higher PE ratio.
PEG (NY)0.33
PEG (5Y)0.05
EPS Next 2Y11.28%
EPS Next 3Y11.16%

6

5. HLBN.DE Dividend Analysis

5.1 Amount

  • HLBN has a Yearly Dividend Yield of 2.56%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.47, HLBN has a dividend in line with its industry peers.
  • HLBN's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.56%

5.2 History

  • On average, the dividend of HLBN grows each year by 9.22%, which is quite nice.
Dividend Growth(5Y)9.22%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • HLBN pays out 13.01% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of HLBN is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP13.01%
EPS Next 2Y11.28%
EPS Next 3Y11.16%
HLBN.DE Yearly Income VS Free CF VS DividendHLBN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
HLBN.DE Dividend Payout.HLBN.DE Dividend Payout, showing the Payout Ratio.HLBN.DE Dividend Payout.PayoutRetained Earnings

HLBN.DE Fundamentals: All Metrics, Ratios and Statistics

HOLCIM LTD

FRA:HLBN (3/27/2026, 7:00:00 PM)

70.7

-1.84 (-2.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-27
Earnings (Next)04-24
Inst Owners43.5%
Inst Owner ChangeN/A
Ins Owners6.72%
Ins Owner ChangeN/A
Market Cap40.08B
Revenue(TTM)15.72B
Net Income(TTM)13.18B
Analysts71.03
Price Target89.81 (27.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.56%
Yearly Dividend3.38
Dividend Growth(5Y)9.22%
DP13.01%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.72%
EPS NY rev (3m)-0.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 2.73
Fwd PE 17.6
P/S 2.34
P/FCF 21.3
P/OCF 13.19
P/B 2.39
P/tB 4.45
EV/EBITDA 12.13
EPS(TTM)25.93
EY36.68%
EPS(NY)4.02
Fwd EY5.68%
FCF(TTM)3.32
FCFY4.69%
OCF(TTM)5.36
OCFY7.58%
SpS30.22
BVpS29.56
TBVpS15.9
PEG (NY)0.33
PEG (5Y)0.05
Graham Number131.32
Profitability
Industry RankSector Rank
ROA 39.22%
ROE 85.7%
ROCE 8.51%
ROIC 5.31%
ROICexc 6.7%
ROICexgc 10.19%
OM 14.18%
PM (TTM) 83.81%
GM 42.34%
FCFM 10.98%
ROA(3y)16.79%
ROA(5y)11.98%
ROE(3y)36.04%
ROE(5y)25.57%
ROIC(3y)5.85%
ROIC(5y)5.22%
ROICexc(3y)6.92%
ROICexc(5y)6.2%
ROICexgc(3y)11.55%
ROICexgc(5y)10.2%
ROCE(3y)9.37%
ROCE(5y)8.38%
ROICexgc growth 3Y9.56%
ROICexgc growth 5Y8.55%
ROICexc growth 3Y12.78%
ROICexc growth 5Y7.97%
OM growth 3Y12.41%
OM growth 5Y2.33%
PM growth 3Y95.17%
PM growth 5Y63.13%
GM growth 3Y2.1%
GM growth 5Y0.23%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 5.35
Debt/EBITDA 2.35
Cap/Depr 95.07%
Cap/Sales 6.75%
Interest Coverage 5.87
Cash Conversion 83.35%
Profit Quality 13.1%
Current Ratio 1.32
Quick Ratio 1.09
Altman-Z 2.84
F-Score4
WACC4.43%
ROIC/WACC1.2
Cap/Depr(3y)117.66%
Cap/Depr(5y)151.25%
Cap/Sales(3y)8.63%
Cap/Sales(5y)11.67%
Profit Quality(3y)71.99%
Profit Quality(5y)46.87%
High Growth Momentum
Growth
EPS 1Y (TTM)355.07%
EPS 3Y63.31%
EPS 5Y54.06%
EPS Q2Q%-131.27%
EPS Next Y8.17%
EPS Next 2Y11.28%
EPS Next 3Y11.16%
EPS Next 5Y9.55%
Revenue 1Y (TTM)-40.46%
Revenue growth 3Y-18.63%
Revenue growth 5Y-7.44%
Sales Q2Q%-42.23%
Revenue Next Year2.7%
Revenue Next 2Y5.02%
Revenue Next 3Y5.02%
Revenue Next 5Y6.3%
EBIT growth 1Y-49.09%
EBIT growth 3Y-8.53%
EBIT growth 5Y-5.28%
EBIT Next Year45.8%
EBIT Next 3Y20.47%
EBIT Next 5Y15.14%
FCF growth 1Y-57.01%
FCF growth 3Y56.1%
FCF growth 5Y-12.51%
OCF growth 1Y-50.8%
OCF growth 3Y-15.14%
OCF growth 5Y-9.6%

HOLCIM LTD / HLBN.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HOLCIM LTD (HLBN.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HLBN.DE.


Can you provide the valuation status for HOLCIM LTD?

ChartMill assigns a valuation rating of 5 / 10 to HOLCIM LTD (HLBN.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for HOLCIM LTD?

HOLCIM LTD (HLBN.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for HLBN stock?

The Price/Earnings (PE) ratio for HOLCIM LTD (HLBN.DE) is 2.73 and the Price/Book (PB) ratio is 2.39.


Can you provide the expected EPS growth for HLBN stock?

The Earnings per Share (EPS) of HOLCIM LTD (HLBN.DE) is expected to grow by 8.17% in the next year.